Max Healthcare Partners with Tata Institute for Genetics and Society to Transform Genomic Healthcare in India, ETHealthworld
New Delhi: Max Healthcare and the Tata Institute for Genetics and Society (TIGS) have signed a Memorandum of Understanding (MoU) to collaborate on advancing healthcare through genomics, research, and innovation.
The agreement aims to create a joint platform for research, training, and knowledge exchange in genetics and clinical science, with a focus on improving patient outcomes through the integration of genomics into healthcare delivery.
The MoU signing ceremony was attended by senior representatives from both institutions. The partnership will centre on collaborative research in rare genetic diseases, neonatal care through genomic insights, and the development of personalised medicine based on genetic profiling.
Under the collaboration, Max Healthcare and TIGS will jointly conduct conferences, workshops, and training programs to facilitate knowledge sharing between scientists, clinicians, and researchers. By combining Max Healthcare’s clinical expertise and patient data with TIGS’s strengths in genomics, the two institutions aim to accelerate the translation of research findings into clinical practice.
Dr. Sandeep Budhiraja, Group Medical Director, Max Healthcare, said, “This partnership with the Tata Institute for Genetics and Society is a significant step forward in our commitment to bringing the latest advancements in medical sciences to our patients. By integrating genomics into our clinical practice, we can move towards a future of more personalised and effective healthcare.”
Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, said, “At TIGS, our mission is to use cutting-edge science to solve societal problems. This collaboration with Max Healthcare provides a unique opportunity to apply our expertise in genomics to real-world clinical challenges and ensure that our research delivers tangible benefits for patients and society.”
The collaboration will particularly advance research in haematology and neonatal care, focusing on understanding the genetic basis of blood disorders, cancers, and critical neonatal conditions. It aims to enable early identification of genetic risk factors and promote personalised treatment strategies, marking a major step toward the broader adoption of genomic medicine in India.
